Now in its 7th year, this is the Nordic region’s leading summit dedicated to bridging biologics R&D with scalable GMP manufacturing – uniting science, digital innovation, and commercial scale-up across the region.
BUILT FOR THE NORDICS
Focused on the region’s core strengths in biologics R&D, process excellence, and smart manufacturing - linking academic, clinical, and commercial stakeholders to drive the full lifecycle from discovery to commercialisation.
WHO
For biopharma and big pharma leaders across the Nordics - from R&D, MSAT, and manufacturing to digital, quality, and strategic teams who are advancing the next generation of biologics. This summit unites R&D, clinical development, Quality Assurance (QA), Manufacturing Science and Technology (MSAT), and manufacturing functions from leading pharmaceutical companies and emerging biotechs.
WHAT
A strategic platform designed to bridge the Nordics' strong biologics R&D capabilities with scalable GMP manufacturing. The summit features two concurrent tracks:
R&D & Clinical Trials and Biologics Manufacturing - offering targeted insights across the full development and production spectrum.
Key themes driving every session include:
- R&D Innovation & Clinical-to-GMP Translation
- Biologics Manufacturing & Scale-Up
- Digitalisation, Automation & Quality
- Strategic & Public-Private Partnerships
Built around the Nordics’ strengths, the event connects academic, clinical, and commercial stakeholders to drive the full lifecycle of biologics from discovery to commercialisation.
WHY
To enable end-to-end collaboration by uniting R&D, clinical development, and manufacturing functions across the entire biologics value chain. The summit aligns these functions through shared challenges, practical insight, and country-specific case studies.
Whether you are focused on achieving scalable production , developing regional infrastructure , or integrating digital technologies like AI and GMP 4.0 , this is where Nordic science meets global strategy.
KEY THEMES & TOPICS
R&D Innovation & Clinical-to-GMP Translation
Delve into breakthroughs in monoclonal antibodies, bispecifics, and RNA-based therapeutics, and navigate the critical transition from preclinical development to GMP-compliant production.
Biologics Manufacturing & Scale-Up
Explore strategies for optimising manufacturing processes, achieving scalable production, and enhancing efficiency through intensified bioprocessing, modular facilities, and single-use technologies.
Digitalisation, Automation & Quality
Discover how digital twins, AI, and advanced process control are enhancing data integrity, compliance, and efficiency across the biomanufacturing lifecycle under GMP 4.0 principles.
Strategic & Public-Private Partnerships
Gain insights on fostering impactful collaborations between industry, academia, and government to build a robust Nordic biologics ecosystem and accelerate innovation.
300+
Senior attendees across biologics manufacturing, biosimilars development, quality, tech ops, regulatory affairs, and strategic partnerships.
50+
Expert speakers shaping the future of biologics and next-generation therapeutics in the Nordics – from early discovery through to commercialisation.
100+
Companies represented, including leading Nordic biotechs, multinational pharmas, pioneering CDMOs, regulators, and academic collaborators.
2 Dedicated Tracks
Insightful content streams across R&D & Clinical Trials and Biologics Manufacturing – tailored to Nordic innovation and production excellence.
Strategic Roundtables & Panels
Deep dives into digital transformation , R&D-to-manufacturing alignment , public-private partnerships, and the future of the biomanufacturing workforce.
Hosted in Stockholm
A dynamic hub for biotech innovation and international life sciences investment – at the heart of the Nordic region.
